FIELD: medicine.
SUBSTANCE: invention relates to transplantation of organs and tissues. Method involves creature of hystohematic barrier between transplant and recipient. Method involves surrounding the transplant by envelope made from membrane biomaterial "Alloplant". Such performance of method provides absence the rejection response of transplant without inhibition of the immune system of body.
EFFECT: improved protecting method.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATING CORNEA DEFECT CASES | 2004 |
|
RU2279887C2 |
| METHOD OF PTERIGIUM SURGICAL TREATMENT | 2007 |
|
RU2327439C1 |
| XENOGENIC BIOMATERIAL FOR REGENERATIVE SURGERY | 2009 |
|
RU2440148C2 |
| METHOD FOR TRANSPLANTING TISSUES AND ORGANS | 1998 |
|
RU2121851C1 |
| BIOLOGICAL CONTAINER FOR CONNECTIVE TISSUE REVASCULISATION | 2008 |
|
RU2369361C1 |
| METHOD FOR PREPARING BIOFUNCTIONAL NANOPARTICLE GRAFT | 2008 |
|
RU2367448C1 |
| METHOD OF PERFORMING THROUGH KERATOPLASTY WITH NATIVE DONOR CORNEA | 2024 |
|
RU2833147C1 |
| METHOD FOR INTEGRATED PATHOGENETIC TREATMENT OF CENTRAL AND PERIPHERAL TAPETORETINAL DYSTROPHIES WITH APPLYING CELL TECHNOLOGIES | 2011 |
|
RU2467730C2 |
| SURGICAL TREATMENT METHOD OF TROPHIC CORNEAL ULCERS ADVANCED AGAINST PARALYTIC LAGOPHTHALMOS | 2008 |
|
RU2368361C1 |
| METHOD FOR STUDYING BIOLOGICAL ACTION OF POTENTIAL BIOMEDICAL CELL PRODUCTS BASED ON HUMAN CELLS IN SUBRETINAL XENOGENEIC TRANSPLANTATION IN EXPERIMENT | 2024 |
|
RU2830558C1 |
